FDA Inspection
VCU Health System Reproductive Medicine and IVFVCU Health System Reproductive Medicine and IVF – FDA Inspection, May 28, 2021
Record Details
This FDA Inspection record concerns VCU Health System Reproductive Medicine and IVF, with an inspection on May 28, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 28, 2021
- Product Type
- Biologics
View Company Profile
ID · c8b96bad-4bf3-472d-9f96-e47110f7b6fb
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1143572
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of VCU Health System Reproductive Medicine and IVF
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 14, 2024 | VAI | Baltimore District Office | Human Cellular, Tissue, and Gene Therapies |
| May 12, 2023 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 1, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for VCU Health System Reproductive Medicine and IVF
- FDA Inspection 1343268 - 2026-10-14
- FDA Inspection 1254107 - 2024-11-14
- FDA Inspection 1205700 - 2023-05-12
- FDA Inspection 1031840 - 2017-11-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.